Cardio Diagnostics Holdings, Inc. CDIO
1.95
0.04
2.09%
as of 25 Sep
- Market cap
- $5.7M
- P/E
- 0.0×
Follow CDIO
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (75.44%) | (65.59%) | (78.62%) | (110.70%) |
+8 more TTM periods Free account |
|
| (70.62%) | (60.91%) | (70.70%) | (98.75%) | ||
ROIC |
(219.40%) | (227.16%) | (217.55%) | (227.44%) | |
Return on Tangible Assets |
(100.86%) | (84.08%) | (108.02%) | (90.08%) | |
Average Days of Receivables |
97.50 | 93.98 | 198.42 | 258.73 | |
Free Cash Flow per Share |
(1.97) | (2.14) | (3.38) | (3.38) | |
Free Cash Flow |
(5.82) | (6.07) | (5.91) | (5.95) | |
Capital Expenditures |
(0.16) | (0.18) | (0.19) | (0.19) | |
Piotroski F-Score |
2.00 | 2.00 | 2.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
(43.49%) | (36.85%) | (47.39%) | (39.69%) | |
Accounts Receivable Turnover |
1.74 | 2.40 | 1.12 | 1.25 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
5,582.88% | 4,616.77% | 5,760.40% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
39,817.12% | 35,793.41% | 38,876.51% | 37,783.54% | |
Share Based Compensation of Revenue |
670.55% | 624.55% | 739.60% | 687.34% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.87 | 0.89 | 0.88 | 0.88 | |
Depreciation/Fixed assets |
0.61 | 0.56 | 0.57 | 0.52 | |
Capex/Depreciation |
(0.44) | (0.50) | (0.47) | (0.49) | |
Revenue per Share |
0.00 | 0.01 | 0.01 | 0.01 | |
Operating CF per Share |
(1.91) | (2.07) | (3.27) | (3.27) | |
Capex per Share |
(0.06) | (0.06) | (0.11) | (0.11) | |
Capex to Sales |
11.27 | 10.98 | 12.57 | 12.09 | |
Net Profit Margin |
(44,312.33%) | (39,828.14%) | (43,612.08%) | (41,468.99%) |
Columns are period end dates